Aspartate Aminotransferases
"Aspartate Aminotransferases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Enzymes of the transferase class that catalyze the conversion of L-aspartate and 2-ketoglutarate to oxaloacetate and L-glutamate. EC 2.6.1.1.
| Descriptor ID |
D001219
|
| MeSH Number(s) |
D08.811.913.477.700.225
|
| Concept/Terms |
Aspartate Aminotransferases- Aspartate Aminotransferases
- Aminotransferases, Aspartate
- Aspartate Apoaminotransferase
- Apoaminotransferase, Aspartate
- Aspartate Transaminase
- Transaminase, Aspartate
- Glutamic-Oxaloacetic Transaminase
- Glutamic Oxaloacetic Transaminase
- Transaminase, Glutamic-Oxaloacetic
- L-Aspartate-2-Oxoglutarate Aminotransferase
- Aminotransferase, L-Aspartate-2-Oxoglutarate
- L Aspartate 2 Oxoglutarate Aminotransferase
- Aspartate Aminotransferase
- Aminotransferase, Aspartate
- Glutamate-Aspartate Transaminase
- Glutamate Aspartate Transaminase
- Transaminase, Glutamate-Aspartate
SGOT- SGOT
- Serum Glutamic-Oxaloacetic Transaminase
- Glutamic-Oxaloacetic Transaminase, Serum
- Serum Glutamic Oxaloacetic Transaminase
- Transaminase, Serum Glutamic-Oxaloacetic
|
Below are MeSH descriptors whose meaning is more general than "Aspartate Aminotransferases".
Below are MeSH descriptors whose meaning is more specific than "Aspartate Aminotransferases".
This graph shows the total number of publications written about "Aspartate Aminotransferases" by people in this website by year, and whether "Aspartate Aminotransferases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 1 | 2 |
| 1997 | 0 | 3 | 3 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 2 | 2 |
| 2002 | 0 | 3 | 3 |
| 2003 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 2 | 3 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 3 | 3 |
| 2011 | 0 | 3 | 3 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 2 | 2 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 3 | 3 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aspartate Aminotransferases" by people in Profiles.
-
Identifying Patients at Risk for Fibrosis in a Primary Care NAFLD Cohort. J Clin Gastroenterol. 2023 Jan 01; 57(1):89-96.
-
Sub-chronic oral toxicity screening of quercetin in mice. BMC Complement Med Ther. 2022 Oct 23; 22(1):279.
-
Normal or near normal aminotransferase levels in patients with alcoholic cirrhosis. Am J Med Sci. 2022 06; 363(6):484-489.
-
Advanced liver fibrosis and the metabolic syndrome in a primary care setting. Diabetes Metab Res Rev. 2021 11; 37(8):e3452.
-
Aldehyde dehydrogenase-2 activation decreases acetaminophen hepatotoxicity by prevention of mitochondrial depolarization. Toxicol Appl Pharmacol. 2020 06 01; 396:114982.
-
Evolving Management Strategies for Nonalcoholic Fatty Liver Disease-Targeting Primary Care Physicians. Diabetes Technol Ther. 2019 11; 21(11):611-618.
-
Predictors of clinical outcomes in cirrhosis patients. Curr Opin Gastroenterol. 2018 07; 34(4):266-271.
-
Evaluation of liver test abnormalities in a patient-centered medical home: do liver test patterns matter? J Investig Med. 2018 12; 66(8):1118-1123.
-
Natural products berberine and curcumin exhibited better ameliorative effects on rats with non-alcohol fatty liver disease than lovastatin. Biomed Pharmacother. 2018 Mar; 99:325-333.
-
Current concepts in ischemic hepatitis. Curr Opin Gastroenterol. 2017 May; 33(3):158-163.